SEC Form 4 · accession 0001645627-17-000116
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Sep 6, 2017
Accepted (ET)
Sep 12, 2017 · 2:42 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 6, 2017 | P | 3,000 | $0.026 | A | 23,133,189 | D | |
| Common Stock | Sep 6, 2017 | P | 3,000 | $0.026 | A | 23,136,189 | D | |
| Common Stock | Sep 6, 2017 | P | 3,000 | $0.026 | A | 23,139,189 | D | |
| Common Stock | Sep 6, 2017 | P | 10,000 | $0.025 | A | 23,149,189 | D | |
| Common Stock | Sep 6, 2017 | P | 5,000 | $0.025 | A | 23,154,189 | D | |
| Common Stock | Sep 6, 2017 | P | 5,000 | $0.025 | A | 23,159,189 | D | |
| Common Stock | Sep 6, 2017 | P | 6,000 | $0.025 | A | 23,165,189 | D | |
| Common Stock | Sep 6, 2017 | P | 5,000 | $0.025 | A | 23,170,189 | D | |
| Common Stock | Sep 6, 2017 | P | 5,000 | $0.026 | A | 23,175,189 | D | |
| Common Stock | Sep 6, 2017 | P | 5,000 | $0.026 | A | 23,180,189 | D | |
| Common Stock | Sep 6, 2017 | P | 5,000 | $0.0259 | A | 23,185,189 | D | |
| Common Stock | Sep 6, 2017 | P | 5,000 | $0.0256 | A | 23,190,189 | D | |
| Common Stock | Sep 6, 2017 | P | 3,000 | $0.0254 | A | 23,193,189 | D | |
| Common Stock | Sep 6, 2017 | P | 3,000 | $0.025 | A | 23,196,189 | D | |
| Common Stock | Sep 6, 2017 | P | 5,000 | $0.025 | A | 23,201,189 | D | |
| Common Stock | Sep 6, 2017 | P | 5,000 | $0.025 | A | 23,206,189 | D | |
| Common Stock | Sep 6, 2017 | P | 5,000 | $0.025 | A | 23,211,189 | D | |
| Common Stock | Sep 6, 2017 | P | 5,000 | $0.0259 | A | 23,216,189 | D | |
| Common Stock | Sep 6, 2017 | P | 3,000 | $0.0269 | A | 23,219,189 | D | |
| Common Stock | Sep 6, 2017 | P | 3,000 | $0.0269 | A | 23,222,189 | D | |
| Common Stock | Sep 6, 2017 | P | 5,000 | $0.0269 | A | 23,227,189 | D | |
| Common Stock | Sep 6, 2017 | P | 5,000 | $0.0268 | A | 23,232,189 | D | |
| Common Stock | Sep 6, 2017 | P | 3,000 | $0.0269 | A | 23,235,189 | D | |
| Common Stock | Sep 7, 2017 | P | 3,000 | $0.0249 | A | 23,238,189 | D | |
| Common Stock | Sep 7, 2017 | P | 5,000 | $0.026 | A | 23,243,189 | D | |
| Common Stock | Sep 7, 2017 | P | 5,000 | $0.026 | A | 23,248,189 | D | |
| Common Stock | Sep 7, 2017 | P | 5,000 | $0.026 | A | 23,253,189 | D | |
| Common Stock | Sep 7, 2017 | P | 3,000 | $0.026 | A | 23,256,189 | D | |
| Common Stock | Sep 7, 2017 | P | 3,000 | $0.026 | A | 23,259,189 | D | |
| Common Stock | Sep 7, 2017 | P | 3,000 | $0.026 | A | 23,262,189 | D |
Table II — derivative securities
No Table II lines on this filing.